Q3 2025 Holdings
Filed 2025-11-14 | 47 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Soleno Therapeutics Inc(SLNO) | Common | 834203309 | $154.0M | 2,278,203 | 12.4% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $148.7M | 1,393,432 | 12.0% |
| Cidara Therapeutics, Inc.(CDTX) | Common | 171757206 | $125.6M | 1,311,425 | 10.1% |
| Terns Pharmaceuticals Inc(TERN) | Common | 880881107 | $51.8M | 6,895,746 | 4.2% |
| Trevi Therapeutics Inc(TRVI) | Common | 89532M101 | $46.6M | 5,094,668 | 3.8% |
| Avadel Pharmaceuticals PLC | ADR | G29687103 | $41.0M | 2,684,109 | 3.3% |
| Cogent Biosciences Inc(COGT) | Common | 19240Q201 | $40.1M | 2,789,137 | 3.2% |
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $38.2M | 5,903,000 | 3.1% |
| Oric Pharmaceuticals Inc(ORIC) | Common | 68622P109 | $37.5M | 3,126,604 | 3.0% |
| Geron Corp(GERN) | Common | 374163103 | $37.3M | 27,225,292 | 3.0% |
| Compass Therapeutics Inc(CMPX) | Common | 20454B104 | $33.4M | 9,545,466 | 2.7% |
| Dyne Therapeutics Inc(DYN) | Common | 26818M108 | $33.1M | 2,614,960 | 2.7% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $30.5M | 359,305 | 2.5% |
| Bright Minds Biosciences Inc(DRUG) | Common | 10919W405 | $30.4M | 501,617 | 2.4% |
| Tourmaline Bio Inc.(TRML) | Common | 89157D105 | $28.3M | 591,882 | 2.3% |
| Zenas Biopharma Inc(ZBIO) | Common | 98937L105 | $26.3M | 1,183,260 | 2.1% |
| Verastem Inc(VSTM) | Common | 92337C203 | $23.4M | 2,644,985 | 1.9% |
| SAB Biotherapeutics Inc(SABS) | Common | 78397T202 | $23.0M | 11,420,000 | 1.8% |
| Viridian Therapeutics Inc(VRDN) | Common | 92790C104 | $21.2M | 982,576 | 1.7% |
| Akero Therapeutics Inc(AKRO) | Common | 00973Y108 | $20.6M | 434,689 | 1.7% |
| Erasca Inc(ERAS) | Common | 29479A108 | $20.2M | 9,273,428 | 1.6% |
| Rezolute Inc(RZLT) | Common | 76200L309 | $19.9M | 2,112,432 | 1.6% |
| Aclaris Therapeutics, Inc.(ACRS) | Common | 00461U105 | $16.9M | 8,888,888 | 1.4% |
| Corvus Pharmaceuticals Holdings(CRVS) | Common | 221015100 | $16.5M | 2,234,566 | 1.3% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $14.7M | 1,505,862 | 1.2% |
| Dianthus Therapeutics Inc(DNTH) | Common | 252828108 | $13.9M | 353,998 | 1.1% |
| LB Pharmaceuticals Inc(LBRX) | Common | 50180M108 | $12.6M | 800,000 | 1.0% |
| Camp4 Therapeutics Inc(CAMP) | Common | 13463J101 | $11.8M | 3,921,568 | 0.9% |
| Astria Therapeutics Inc(CATBUSD) | Common | 04635X102 | $11.3M | 1,552,685 | 0.9% |
| Pepgen Inc(PEPG) | Common | 713317105 | $10.7M | 2,325,000 | 0.9% |
| DBV Technologies SA(DBVT) | SPONSORED ADS | 23306J309 | $10.5M | 1,054,506 | 0.8% |
| Praxis Precision Medicines(PRAX) | Common | 74006W207 | $10.5M | 198,895 | 0.8% |
| Abeona Therapeutics, Inc.(ABEO) | Common | 00289Y206 | $9.7M | 1,842,751 | 0.8% |
| Cytomx Therapeutics Inc(CTMX) | Common | 23284F105 | $9.2M | 2,884,615 | 0.7% |
| Eupraxia Pharmaceuticals Inc(EPRX) | Common | 29842P105 | $8.0M | 1,350,000 | 0.6% |
| Unicycive Therapeutics(UNCY) | Common | 90466Y202 | $7.8M | 1,789,916 | 0.6% |
| Monopar Therapeutics Inc(MNPR) | Common | 61023L207 | $7.4M | 90,500 | 0.6% |
| Tango Therapeutics Inc(TNGX) | Common | 87583X109 | $6.5M | 776,699 | 0.5% |
| Delcath Systems, Inc.(DCTH) | Common | 24661P807 | $6.1M | 569,526 | 0.5% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $5.7M | 1,105,454 | 0.5% |
| 89Bio Inc(ETNBGBP) | Common | 282559103 | $5.5M | 376,804 | 0.4% |
| Instil Bio Inc(TIL) | Common | 45783C200 | $5.2M | 292,743 | 0.4% |
| Sera Prognostics Inc(SERA) | Common | 81749D107 | $5.1M | 1,650,440 | 0.4% |
| Surrozen Inc(SRZN) | Common | 86889P208 | $3.4M | 260,000 | 0.3% |
| Tenax Therapeutics Inc(TENX) | Common | 88032L605 | $1.6M | 208,333 | 0.1% |
| Bolt Therapeutics Inc(BOLT) | Common | 097702203 | $936.7K | 176,064 | 0.1% |
| Precision Biosciences Inc(DTIL) | Common | 74019P207 | $25.8K | 4,675 | 0.0% |